IGC Pharma (FRA:IGS1) Days Sales Outstanding : 51.72 (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is IGC Pharma Days Sales Outstanding?

IGC Pharma's average Accounts Receivable for the three months ended in Dec. 2023 was €0.11 Mil. IGC Pharma's Revenue for the three months ended in Dec. 2023 was €0.19 Mil. Hence, IGC Pharma's Days Sales Outstanding for the three months ended in Dec. 2023 was 51.72.

The historical rank and industry rank for IGC Pharma's Days Sales Outstanding or its related term are showing as below:

FRA:IGS1' s Days Sales Outstanding Range Over the Past 10 Years
Min: 9.73 Med: 59.33 Max: 539.95
Current: 48.75

During the past 13 years, IGC Pharma's highest Days Sales Outstanding was 539.95. The lowest was 9.73. And the median was 59.33.

FRA:IGS1's Days Sales Outstanding is ranked better than
70.34% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs FRA:IGS1: 48.75

IGC Pharma's Days Sales Outstanding declined from Dec. 2022 (62.39) to Dec. 2023 (51.72).

IGC Pharma Days Sales Outstanding Historical Data

The historical data trend for IGC Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IGC Pharma Days Sales Outstanding Chart

IGC Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

21.24

9.61

64.63

132.31

45.89

IGC Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															62.39	99.20	27.45	56.15	51.72

Competitive Comparison of IGC Pharma's Days Sales Outstanding

For the Biotechnology subindustry, IGC Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IGC Pharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IGC Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where IGC Pharma's Days Sales Outstanding falls into.

IGC Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

IGC Pharma's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (0.114	+	0.1)	/	2 )	/	0.851	*	365
=	0.107					/	0.851	*	365
=	45.89

IGC Pharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.128	+	0.084)	/	2 )	/	0.187	*	365 / 4
=	0.106					/	0.187	*	365 / 4
=	51.72

IGC Pharma (FRA:IGS1) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

IGC Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of IGC Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

IGC Pharma (FRA:IGS1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IGC Pharma Inc (FRA:IGS1) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IGC:USA

Address

10224 Falls Road, Potomac, MD, USA, 20854

Website

https://www.igcinc.us

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

IGC Pharma (FRA:IGS1) Headlines

No Headlines